Catalyst Wire Dossier Catalyst Wire Dossier

Zanubritnib

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zanubritnib, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Zanubritnib and Anti-MAG Neuropathy [Phase 2]

See pricing